Clinical Trials Directory

Trials / Completed

CompletedNCT04613700

The Role of Secretin on the Energy Homeostasis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Steno Diabetes Center Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

As of last year, new insight into the function of secretin was brought about as rodent studies showed secretin to possess potential body weight-regulating effects. In these studies, secretin was shown to increase non-shivering thermogenesis in brown adipose tissue (BAT), decrease meal size and promote meal discontinuation. The mechanisms behind these regulatory effect of secretin on energy homeostasis are unclear,

Detailed description

Secretin was - as the first hormone - identified in 19021, but was not isolated until the 1960s. Secretin is produced in and secreted form small intestinal S cells. In the 1970s, the primary endocrine effects of secretin were unequivocally confirmed, namely potentiation of bicarbonate and pepsin secretion from the pancreas as well as stimulation of bile production in the liver. In the 1990s, the biosynthesis of secretin was delineated and its receptor was discovered. In the 2000s the pancreatic regulation of intestinal pH was shown to be secretin-mediated. As of last year, new insight into the function of secretin was brought about as rodent studies showed secretin to possess potential body weight-regulating effects. In these studies, secretin was shown to increase non-shivering thermogenesis in brown adipose tissue (BAT), decrease meal size and promote meal discontinuation. The primary aim of this study is to evaluate the effect of a 5-hour intravenous infusion with the naturally occurring hormone secretin on ad libitum food intake (primary endpoint) compared to a double-blinded placebo (isotonic saline) infusion in 25 healthy young males.

Conditions

Interventions

TypeNameDescription
DRUGSecretinNative hormone
OTHERPlaceboSaline

Timeline

Start date
2020-03-01
Primary completion
2020-09-29
Completion
2020-09-29
First posted
2020-11-03
Last updated
2020-11-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04613700. Inclusion in this directory is not an endorsement.